Sanofi ADR
Sanofi ADR (SNY) Covered Calls
Sanofi ADR trades in the Drug Manufacturers - General industry with an IV Rank of 65.67%, average versus the past year. SNY's highest covered call setup is the $50.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 3.91% out of the money with 11 days to expiration, a 4.43% return until expiration, and a 146.88% theoretical annualized return. Across the setups shown, annualized returns run from 50.97% to 146.88% at strikes between $50.00 and $75.00, with 11 to 403 days to expiration, as of Nov 9, 2026.
Read more
Running SNY covered calls helps you generate income from Sanofi ADR shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best SNY covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If SNY stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling SNY covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given SNY covered call is worth writing.
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines.
| 2026-11-20 | 11 | 50.00 | 3.91 | 0.25 | 0.55 | 213.00 | 4.43 | 146.88 | -0.52 | +0.26 | 244 | 0.30 |
| 2027-01-15 | 67 | 57.50 | 19.49 | 0.10 | 0.25 | 948.00 | 19.70 | 107.32 | -0.21 | +0.07 | 233 | 0.15 |
| 2026-12-18 | 39 | 52.50 | 9.10 | 0.30 | 0.55 | 468.00 | 9.73 | 91.02 | -0.62 | +0.19 | 435 | 0.25 |
| 2027-01-15 | 67 | 55.00 | 14.30 | 0.25 | 1.20 | 713.00 | 14.82 | 80.72 | -0.52 | +0.20 | 921 | 0.95 |
| 2027-06-17 | 220 | 70.00 | 45.47 | 0.10 | 0.30 | 2198.00 | 45.68 | 75.78 | -0.21 | +0.05 | 46 | 0.20 |
| 2027-03-19 | 130 | 60.00 | 24.69 | 0.25 | 0.45 | 1213.00 | 25.21 | 70.78 | -0.52 | +0.10 | 145 | 0.20 |
| 2027-06-17 | 220 | 65.00 | 35.08 | 0.25 | 0.45 | 1713.00 | 35.60 | 59.06 | -0.52 | +0.09 | 11 | 0.20 |
| 2027-01-15 | 67 | 52.50 | 9.10 | 0.75 | 0.85 | 513.00 | 10.66 | 58.08 | -1.56 | +0.26 | 685 | 0.10 |
| 2026-12-18 | 39 | 50.00 | 3.91 | 0.90 | 1.20 | 278.00 | 5.78 | 54.07 | -1.87 | +0.37 | 901 | 0.30 |
| 2027-12-17 | 403 | 75.00 | 55.86 | 0.20 | 0.60 | 2708.00 | 56.28 | 50.97 | -0.42 | +0.08 | 19 | 0.40 |
As of Nov 9, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryDrug Manufacturers - General
- SectorHealthcare
- IV Rank65.67% Moderate
- Market cap (M$)114,955
- 52 weeks high-8.45%
- 52 weeks low23.45%
- Analyst recommendationBuy
1.90 - Target price$52.56
8.98% above the current stock price - Dividend—
- Payout ratio73.36%
- Earnings date2027-02-04
- P/E24.84
- Future P/E9.12
- EPS (ttm)1.94
- EPS growth next 5 years7.29%
As of Nov 10, 2026